Related references
Note: Only part of the references are listed.Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ling Ni et al.
IMMUNITY (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
Barry Rockx et al.
SCIENCE (2020)
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines
Paul-Henri Lambert et al.
VACCINE (2020)
A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies
Niraj Mishra et al.
MBIO (2020)
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
Sin Fun Sia et al.
NATURE (2020)
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
Hui Wang et al.
CELL (2020)
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Christopher O. Barnes et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection
J. Erin Staples et al.
NPJ VACCINES (2020)
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Jingyun Yang et al.
NATURE (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates
Jesse H. Erasmus et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine
Sapna Sharma et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Direct visualization of translational GTPase factor pool formed around the archaeal ribosomal P-stalk by high-speed AFM
Hirotatsu Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
Robbert Boudewijns et al.
NATURE COMMUNICATIONS (2020)
Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final Report
Rebecca M. Casey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Radiosafe micro-computed tomography for longitudinal evaluation of murine disease models
Nathalie Berghen et al.
SCIENTIFIC REPORTS (2019)
Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization
Hannah Kleine-Weber et al.
JOURNAL OF VIROLOGY (2019)
Viral-Induced Enhanced Disease Illness
Maria K. Smatti et al.
FRONTIERS IN MICROBIOLOGY (2018)
A recombinant live attenuated tetravalent vaccine for the prevention of dengue
Bruno Guy et al.
EXPERT REVIEW OF VACCINES (2017)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Zika virus infection of adult and fetal STAT2 knock-out hamsters
Venkatraman Siddharthan et al.
VIROLOGY (2017)
Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume
Greetje Vande Velde et al.
DISEASE MODELS & MECHANISMS (2016)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining
Jonathan M. Geisinger et al.
NUCLEIC ACIDS RESEARCH (2016)
Baby hamster kidney cell-derived recombinant factor VIII: a quarter century of learning and clinical experience
Olubunmi Afonja et al.
EXPERT REVIEW OF HEMATOLOGY (2016)
The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+but not CD8+T Cells
Alan M. Watson et al.
PLOS PATHOGENS (2016)
Spectrum of disease outcomes in mice infected with YFV-17D
Andrea K. Erickson et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis
Nadia Conceicao-Neto et al.
SCIENTIFIC REPORTS (2015)
The yellow fever 17D virus as a platform for new live attenuated vaccines
Myrna C. Bonaldo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Simple and inexpensive three-step rapid amplification of cDNA 5′ ends using 5′ phosphorylated primers
Kai Dallmeier et al.
ANALYTICAL BIOCHEMISTRY (2013)
Iterative CT Reconstruction Using Shearlet-Based Regularization
Bert Vandeghinste et al.
IEEE TRANSACTIONS ON NUCLEAR SCIENCE (2013)
Dynamic Viral Dissemination in Mice Infected with Yellow Fever Virus Strain 17D
Andrea K. Erickson et al.
JOURNAL OF VIROLOGY (2013)
Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: A systematic review
Ellen Rafferty et al.
VACCINE (2013)
17DD yellow fever vaccine A double blind, randomized clinical trial of immunogenicity and safety on a dose-response study
Reinaldo M. Martins et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
The Safety of Yellow Fever Vaccine 17D or 17DD in Children, Pregnant Women, HIV+ Individuals, and Older Persons: Systematic Review
Roger E. Thomas et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Induction of Alternatively Activated Macrophages Enhances Pathogenesis during Severe Acute Respiratory Syndrome Coronavirus Infection
Carly Page et al.
JOURNAL OF VIROLOGY (2012)
A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon
Marianne Berger Rentsch et al.
PLOS ONE (2011)
IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine
Mohan Babu Appaiahgari et al.
EXPERT REVIEW OF VACCINES (2010)
Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines
Michael A. Whitt
JOURNAL OF VIROLOGICAL METHODS (2010)
Viruses as vaccine vectors for infectious diseases and cancer
Simon J. Draper et al.
NATURE REVIEWS MICROBIOLOGY (2010)
WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009
Morag Ferguson et al.
VACCINE (2010)
Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
Alan D. T. Barrett et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection
Kathryn C. Meier et al.
PLOS PATHOGENS (2009)
Yellow fever 17-d vaccine is neurotropic and produces encephalitis in Immunosuppressed hamsters
Rosa I. Mateo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
Construction and characterization of recombinant flaviviruses bearing insertions between E and NSI genes
Myrna C. Bonaldo et al.
VIROLOGY JOURNAL (2007)
High stability of yellow fever 17D-204 vaccine:: A 12-year restrospective analysis of large-scale production
V. Barban et al.
VACCINE (2007)
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins
PJ Bredenbeek et al.
VIROLOGY (2006)
Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein
S Fukushi et al.
JOURNAL OF GENERAL VIROLOGY (2005)
The transmembrane domains of the prM and E proteins of yellow fever virus are endoplasmic reticulum localization signals
AO De Beeck et al.
JOURNAL OF VIROLOGY (2004)
Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis
RB Tesh et al.
EMERGING INFECTIOUS DISEASES (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
